•
Oct 01, 2022

Thermo Fisher Q3 2022 Earnings Report

Delivered strong financial results driven by growth strategy and powered by PPI Business System.

Key Takeaways

Thermo Fisher Scientific reported strong financial results for the third quarter of 2022. Revenue grew 14% to $10.68 billion, with a Core organic revenue growth of 14%. GAAP diluted EPS was $3.79, and adjusted EPS was $5.08. The company launched innovative new products and expanded capacity with new facilities.

Third quarter revenue was $10.68 billion.

Third quarter GAAP diluted earnings per share (EPS) was $3.79.

Third quarter adjusted EPS was $5.08.

Delivered very strong financial results in the third quarter, with 14% Core organic revenue growth and $0.44 billion of COVID-19 testing revenue.

Total Revenue
$10.7B
Previous year: $9.33B
+14.4%
EPS
$5.08
Previous year: $5.76
-11.8%
Organic Revenue Growth
-1%
Previous year: 7%
-114.3%
Gross Profit
$4.43B
Previous year: $4.8B
-7.6%
Cash and Equivalents
$2.92B
Previous year: $12B
-75.7%
Free Cash Flow
$1.39B
Previous year: $2.13B
-34.6%
Total Assets
$90.5B
Previous year: $73.6B
+23.0%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

The company will provide updated 2022 financial guidance during its earnings conference call this morning at 8:30 a.m. Eastern Time.

Revenue & Expenses

Visualization of income flow from segment revenue to net income